Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabrina Lisi

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Clinical and Experimental Medicine|March 26, 2014
The metalloproteinase ADAM17 and the epidermal growth factor receptor (EGFR) signaling drive the inflammatory epithelial response in Sjögren's syndromeMargherita Sisto, Sabrina Lisi, Massimo D'Amore, et al.
Immunology|March 25, 2014
Rituximab-mediated Raf kinase inhibitor protein induction modulates NF-κB in Sjögren syndromeMargherita Sisto, Sabrina Lisi, Massimo D'Amore, et al.
International Immunology|November 10, 2014
Co-culture system of human salivary gland epithelial cells and immune cells from primary Sjögren's syndrome patients: an in vitro approach to study the effects of Rituximab on the activation of the Raf-1/ERK1/2 pathwaySabrina Lisi, Margherita Sisto, Massimo D'Amore, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 12, 2020
TGFβ1-Smad canonical and -Erk noncanonical pathways participate in interleukin-17-induced epithelial-mesenchymal transition in Sjögren's syndromeMargherita Sisto, Loredana Lorusso, Giuseppe Ingravallo, et al.
Recenti Progressi in Medicina|April 4, 2013
[Paget's disease of bone: new therapeutic strategies]Massimo D'Amore, Sabrina Lisi, Margherita Sisto, et al.
Recenti Progressi in Medicina|January 28, 2011
[The treatment of the glucocorticoids-induced osteoporosis: recent knowledge]Anna Valentina De Marino, Sabrina Lisi, Margherita Sisto, et al.
Histochemistry and Cell Biology|January 13, 2012
Neuropilin-1 is upregulated in Sjögren's syndrome and contributes to pathological neovascularizationMargherita Sisto, Sabrina Lisi, Dario Domenico Lofrumento, et al.
Cytokine|January 24, 2013
Emerging avenues linking inflammation, angiogenesis and Sjögren's syndromeSabrina Lisi, Margherita Sisto, Massimo D'Amore, et al.
Clinical and Experimental Medicine|May 11, 2010
Advances in the understanding of the Fc gamma receptors-mediated autoantibodies uptakeSabrina Lisi, Margherita Sisto, Dario Domenico Lofrumento, et al.
Mediators of Inflammation|January 2, 2019
The TGF-<i>β</i>1 Signaling Pathway as an Attractive Target in the Fibrosis Pathogenesis of Sjögren's SyndromeMargherita Sisto, Loredana Lorusso, Giuseppe Ingravallo, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Clinical and Experimental Medicine|March 26, 2014
The metalloproteinase ADAM17 and the epidermal growth factor receptor (EGFR) signaling drive the inflammatory epithelial response in Sjögren's syndromeMargherita Sisto, Sabrina Lisi, Massimo D'Amore, et al.
Immunology|March 25, 2014
Rituximab-mediated Raf kinase inhibitor protein induction modulates NF-κB in Sjögren syndromeMargherita Sisto, Sabrina Lisi, Massimo D'Amore, et al.
International Immunology|November 10, 2014
Co-culture system of human salivary gland epithelial cells and immune cells from primary Sjögren's syndrome patients: an in vitro approach to study the effects of Rituximab on the activation of the Raf-1/ERK1/2 pathwaySabrina Lisi, Margherita Sisto, Massimo D'Amore, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 12, 2020
TGFβ1-Smad canonical and -Erk noncanonical pathways participate in interleukin-17-induced epithelial-mesenchymal transition in Sjögren's syndromeMargherita Sisto, Loredana Lorusso, Giuseppe Ingravallo, et al.
Recenti Progressi in Medicina|April 4, 2013
[Paget's disease of bone: new therapeutic strategies]Massimo D'Amore, Sabrina Lisi, Margherita Sisto, et al.
Recenti Progressi in Medicina|January 28, 2011
[The treatment of the glucocorticoids-induced osteoporosis: recent knowledge]Anna Valentina De Marino, Sabrina Lisi, Margherita Sisto, et al.
Histochemistry and Cell Biology|January 13, 2012
Neuropilin-1 is upregulated in Sjögren's syndrome and contributes to pathological neovascularizationMargherita Sisto, Sabrina Lisi, Dario Domenico Lofrumento, et al.
Cytokine|January 24, 2013
Emerging avenues linking inflammation, angiogenesis and Sjögren's syndromeSabrina Lisi, Margherita Sisto, Massimo D'Amore, et al.
Clinical and Experimental Medicine|May 11, 2010
Advances in the understanding of the Fc gamma receptors-mediated autoantibodies uptakeSabrina Lisi, Margherita Sisto, Dario Domenico Lofrumento, et al.
Mediators of Inflammation|January 2, 2019
The TGF-<i>β</i>1 Signaling Pathway as an Attractive Target in the Fibrosis Pathogenesis of Sjögren's SyndromeMargherita Sisto, Loredana Lorusso, Giuseppe Ingravallo, et al.
Pageof 7